Abstract:Background Turner's syndrome (TS) is the most common genetic abnormality affecting females and is characterised by complete or partial absence of the X chromosome. Mortality is predominantly related to cardiovascular disease (1). Risk of life-threatening aortic dissection is 40 per 100,000 (2). Indexed aorta size (ASI) to body surface area (BSA) >20mm/m2 is considered abnormal. An ASI of ≥25mm/m2 is associated with increased risk of aortic dissection (3). Despite this there is a paucity of data in the literature regarding TS cardiovascular disease and providing evidence-based care can be challenging. Purpose Define cardiovascular disease, with focus upon aortopathy in our TS Cardiovascular Clinic (TCC). Methods Single centre retrospective medical record analysis of 248 women with TS (2021-2024) Results Patient baseline characteristics; mean age 37 years (range 18-75yrs), height 150cm (132-169cm), weight 62kg (37-130kg), BSA 1.55m2 (1.19-2.17m2). 65 patients (29%) had bicuspid aortic valve (BAV), 19 (8%) and 5 (3%) had repaired and un-repaired aortic coarctation (CoA) respectively. 30 (13%) had other congenital heart disease, with most common was partial anomalous pulmonary venous connection (12 patients: 5%). 22/248 patients had previous aortic root surgery; 20 elective (mean ASI 29mm/m2, range 26-33mm/m2, mean age at time of surgery 42 years); 2 presented with aortic dissection (ASI 21mm/m2; pregnant, BAV & 24mm/m2; tri-leaflet aortic valve, TAV). Data was available for 221 unoperated patients (figure 1). The site of maximal dimension was observed at the sinus of Valsalva in 70% compared to 30% at the ascending aorta. 130 patients (59%) had maximal ASI of 25mm/m2. 4 patients (2%) had an absolute maximal dimension of 40mm with ASI of 23mm/m2 for all four. 9/11 patients with dimension ≥25mm/m2 or 40mm had a body mass index (BMI) >25kg/m2. Review of medical history for patients at and above threshold for risk of aortic dissection revealed referral to or previous discussion in an Aortic multi-disciplinary meeting (MDT) with a plan for ongoing surveillance. 57 patients (35%) with TAV had significant aortopathy (mean age 46years, range 19-75years) compared with 33 (51%) with BAV (mean age 39yrs, range 22-72 years) (figure 2). Review of patients >55years of age demonstrated a very similar burden of aortopathy in both TAV (14%) and BAV (15%) populations. Conclusions A high burden of cardiovascular disease exists within our TS population. There is a very high prevalence of aortopathy, increasingly with age and both with and without the presence of a bicuspid aortic valve. More published data is needed to help better define those at risk.

Increased detection of co-morbidities with evaluation at a dedicated adult Turner syndrome clinic

Height Standard Deviation Score is Related to Karyotypes and Birth Weight in Girls with Turner Syndrome

The Natural History of Metabolic Comorbidities in Turner Syndrome from Childhood to Early Adulthood: Comparison between 45,X Monosomy and Other Karyotypes

The introduction of a dedicated cardiology clinic including a clinical scientist led pathway for women with turner's syndrome

Psychiatric disorders and comorbidity in women with Turner Syndrome: a retrospective national cohort study

Turner Syndrome: Pitfalls of Transition from Paediatric to Adult Health Care

New insights into the comorbid conditions of Turner syndrome: results from a long-term monocentric cohort study

Current best practice in the management of Turner syndrome

Increased Colorectal Cancer Rate in Turner Syndrome: A Case Control Study

Are Young People with Turner Syndrome Who Have Undergone Treatment with Growth and Sex Hormones at Higher Risk of Metabolic Syndrome and Its Complications?

Turner Syndrome where are we?

Growth During Pubertal Induction in Girls With Turner Syndrome: A Retrospective Cohort Analysis

A Diagnosis of Turner Syndrome in the Eighth Decade of Life

Cardiovascular health in women with turner's syndrome: a 3-year single centre audit

Comprehensive Oral Diagnosis and Management for Women with Turner Syndrome

Increased Insulin Concentrations During Growth Hormone Treatment in Girls With Turner Syndrome Are Ameliorated by Hormone Replacement Therapy

Liver biochemical abnormalities in Turner syndrome: A comprehensive characterization of an adult population

Cardiovascular Manifestations of Turner Syndrome: Phenotypic Differences Between Karyotype Subtypes

Carotid Intima-Media Thickness and Cardiometabolic Profile in Turner Syndrome: A Cross-Sectional Study

Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group

Fertility and pregnancy outcomes in women with Turner syndrome: A single centre experience